Loading...
XNASWBA
Market cap7.96bUSD
Jan 08, Last price  
9.22USD
1D
-4.65%
1Q
2.10%
Jan 2017
-88.86%
IPO
-87.90%
Name

Walgreens Boots Alliance Inc

Chart & Performance

D1W1MN
XNAS:WBA chart
P/E
—
P/S
0.05
EPS
—
Div Yield, %
15.83%
Shrs. gr., 5y
-1.34%
Rev. gr., 5y
1.53%
Revenues
147.66b
+6.17%
42,201,600,00047,409,000,00053,762,000,00059,034,300,00063,335,000,00067,420,000,00072,184,000,00071,633,000,00072,217,000,00076,392,000,000103,444,000,000117,351,000,000118,214,000,000131,537,000,000136,866,000,000139,537,000,000132,509,000,000132,703,000,000139,081,000,000147,658,000,000
Net income
-8.64b
L+180.39%
1,559,500,0001,750,600,0002,041,300,0002,156,700,0002,006,000,0002,091,000,0002,714,000,0002,127,000,0002,450,000,0001,932,000,0004,220,000,0004,173,000,0004,078,000,0005,024,000,0003,982,000,000456,000,0001,328,000,0004,337,000,000-3,080,000,000-8,636,000,000
CFO
1.02b
-54.92%
1,371,200,0002,439,600,0002,356,700,0003,039,000,0004,111,000,0003,744,000,0003,643,000,0004,431,000,0004,301,000,0003,893,000,0005,664,000,0007,847,000,0007,251,000,0008,265,000,0005,594,000,0005,484,000,0005,555,000,0003,899,000,0002,258,000,0001,018,000,000
Dividend
Aug 21, 20240.25 USD/sh
Earnings
Mar 26, 2025

Profile

Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company is headquartered in Deerfield, Illinois and currently employs 232,000 full-time employees. The firm is a pharmacy-led health and wellbeing company. The firm operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The firm's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.
URL
https://www.walgreensbootsalliance.com/
IPO date
Dec 31, 2014
Employees
325,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑082023‑082022‑082021‑082020‑082019‑082018‑082017‑082016‑082015‑08
Income
Revenues
147,658,000
6.17%
139,081,000
4.81%
132,703,000
0.15%
Cost of revenue
147,449,000
137,859,000
132,039,000
Unusual Expense (Income)
NOPBT
209,000
1,222,000
664,000
NOPBT Margin
0.14%
0.88%
0.50%
Operating Taxes
1,246,000
1,858,000
(30,000)
Tax Rate
596.17%
152.05%
NOPAT
(1,037,000)
(636,000)
694,000
Net income
(8,636,000)
180.39%
(3,080,000)
-171.02%
4,337,000
226.58%
Dividends
(1,260,000)
(1,659,000)
(1,659,000)
Dividend yield
15.78%
7.59%
5.46%
Proceeds from repurchase of equity
(69,000)
(150,000)
(160,000)
BB yield
0.86%
0.69%
0.53%
Debt
Debt current
2,456,000
3,265,000
3,345,000
Long-term debt
54,176,000
54,740,000
55,935,000
Deferred revenue
6,261,000
Other long-term liabilities
10,827,000
5,755,000
3,559,000
Net debt
51,249,000
53,769,000
51,313,000
Cash flow
Cash from operating activities
1,018,000
2,258,000
3,899,000
CAPEX
(1,381,000)
(2,117,000)
(1,734,000)
Cash from investing activities
1,878,000
(3,094,000)
(1,064,000)
Cash from financing activities
(538,000)
(887,000)
(1,499,000)
FCF
2,400,000
2,321,000
1,506,000
Balance
Cash
3,109,000
739,000
2,472,000
Long term investments
2,274,000
3,497,000
5,495,000
Excess cash
1,331,850
Stockholders' equity
22,197,000
38,546,000
36,050,000
Invested Capital
55,345,000
74,040,000
68,028,150
ROIC
1.09%
ROCE
0.37%
1.62%
0.94%
EV
Common stock shares outstanding
863,100
863,200
865,900
Price
9.25
-63.45%
25.31
-27.81%
35.06
-30.92%
Market cap
7,983,675
-63.46%
21,847,592
-28.03%
30,358,454
-30.96%
EV
60,967,675
84,085,592
82,713,454
EBITDA
2,668,000
3,479,000
2,654,000
EV/EBITDA
22.85
24.17
31.17
Interest
482,000
580,000
400,000
Interest/NOPBT
230.62%
47.46%
60.24%